165 related articles for article (PubMed ID: 15732290)
1. Mycophenolate mofetil in lupus nephritis.
Ginzler EM; Aranow C
Lupus; 2005; 14(1):59-64. PubMed ID: 15732290
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis.
Moore RA; Derry S
Arthritis Res Ther; 2006; 8(6):R182. PubMed ID: 17163990
[TBL] [Abstract][Full Text] [Related]
3. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.
Ginzler EM; Wofsy D; Isenberg D; Gordon C; Lisk L; Dooley MA;
Arthritis Rheum; 2010 Jan; 62(1):211-21. PubMed ID: 20039429
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil vs. cyclophosphamide-based induction regimens for lupus nephritis: Outcomes at a tertiary care centre in Lahore, Pakistan.
Saeed MA; Khan A; Naeem F; Ahmad NM
J Pak Med Assoc; 2024 May; 74(5):868-873. PubMed ID: 38783432
[TBL] [Abstract][Full Text] [Related]
5. Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide.
Chbihi M; Eveillard LA; Riller Q; Brousse R; Berthaud R; Quartier P; Salomon R; Charbit M; Avramescu M; Biebuyck N; Dehoux L; Garcelon N; Duong-Van-Huyen JP; Bader-Meunier B; Boyer O
J Nephrol; 2023 Apr; 36(3):829-839. PubMed ID: 36208405
[TBL] [Abstract][Full Text] [Related]
6. Therapy of lupus nephritis: lessons learned from clinical research and daily care of patients.
Houssiau FA
Arthritis Res Ther; 2012 Jan; 14(1):202. PubMed ID: 22293173
[TBL] [Abstract][Full Text] [Related]
7. Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis.
Kawazoe M; Nanki T
Lupus; 2024 Apr; 33(4):319-327. PubMed ID: 38232223
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis.
Singh JA; Hossain A; Kotb A; Wells GA
Syst Rev; 2016 Sep; 5(1):155. PubMed ID: 27619512
[TBL] [Abstract][Full Text] [Related]
9. Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis.
Singh JA; Hossain A; Kotb A; Wells G
BMC Med; 2016 Sep; 14(1):137. PubMed ID: 27623861
[TBL] [Abstract][Full Text] [Related]
10. Can we identify who gets benefit or harm from mycophenolate mofetil in systemic lupus erythematosus? A systematic review.
Mendoza-Pinto C; Pirone C; van der Windt DA; Parker B; Bruce IN
Semin Arthritis Rheum; 2017 Aug; 47(1):65-78. PubMed ID: 28325471
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate-induced colitis in a patient with lupus nephritis: a case report and review of the literature.
Alakkas Z; Gari AM; Makhdoum S; AlSindi EA
J Med Case Rep; 2024 May; 18(1):229. PubMed ID: 38689344
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the Clinical Effects of the Combination of Mycophenolate Mofetil with Either Tacrolimus or Cyclophosphamide.
Zhang X; Liu P; Zhang Z
Clinics (Sao Paulo); 2020; 75():e1820. PubMed ID: 33206751
[TBL] [Abstract][Full Text] [Related]
13. Genetic Polymorphisms Associated with Cyclophosphamide Outcome and Risk of Toxicity in Patients with Lupus Nephritis.
Indrawijaya YYA; Hamijoyo L; Artarini AA; Iwo MI
Acta Med Indones; 2023 Jul; 55(3):343-349. PubMed ID: 37915145
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial.
Saxena A; Ginzler EM; Gibson K; Satirapoj B; Santillán AEZ; Levchenko O; Navarra S; Atsumi T; Yasuda S; Chavez-Perez NN; Arriens C; Parikh SV; Caster DJ; Birardi V; Randhawa S; Lisk L; Huizinga RB; Teng YKO
Arthritis Rheumatol; 2024 Jan; 76(1):59-67. PubMed ID: 37466424
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil as induction and long-term maintenance therapy in childhood cerebral vasculitis: a case series.
Pagnini I; Mortilla M; Gentile D; Maccora I; Abu-Rumeileh S; Limbucci N; Simonini G; Rosati A
Rheumatology (Oxford); 2023 Dec; 62(12):e345-e348. PubMed ID: 37233120
[No Abstract] [Full Text] [Related]
16. After 4 Decades of Lupus Nephritis Trials, Is There a "Best" Therapy?
Bomback AS
Am J Kidney Dis; 2017 Sep; 70(3):309-310. PubMed ID: 28842060
[No Abstract] [Full Text] [Related]
17. Successful treatment of HIV-associated lupus-like glomerulonephritis with mycophenolic acid.
Tiong M; Wilson S; Pham A; Chrysostomou A
Clin Case Rep; 2020 Sep; 8(9):1601-1604. PubMed ID: 32983458
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
Dooley MA; Jayne D; Ginzler EM; Isenberg D; Olsen NJ; Wofsy D; Eitner F; Appel GB; Contreras G; Lisk L; Solomons N;
N Engl J Med; 2011 Nov; 365(20):1886-95. PubMed ID: 22087680
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.
Appel GB; Contreras G; Dooley MA; Ginzler EM; Isenberg D; Jayne D; Li LS; Mysler E; Sánchez-Guerrero J; Solomons N; Wofsy D;
J Am Soc Nephrol; 2009 May; 20(5):1103-12. PubMed ID: 19369404
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
